Gluconorm G2 D Tablet SR

Gluconorm G2 D Tablet SR combines Glimepiride, Metformin, and Vitamin D, offering a multi-mechanism approach for the management of type 2 diabetes mellitus.

Glimepiride belongs to the sulfonylurea class of oral antidiabetic medicines. It stimulates insulin secretion from functioning pancreatic beta cells by closing ATP-sensitive potassium channels, leading to membrane depolarisation and insulin release. This helps lower postprandial and fasting blood glucose levels.

Metformin belongs to the biguanide class and is widely considered a first-line medicine in type 2 diabetes. It primarily reduces hepatic glucose production, improves peripheral insulin sensitivity, and decreases intestinal glucose absorption. Unlike sulfonylureas, Metformin does not directly stimulate insulin secretion and therefore carries a lower independent risk of hypoglycaemia.

Vitamin D is included to support metabolic and musculoskeletal health. Vitamin D deficiency is commonly observed in individuals with diabetes and may influence insulin sensitivity, muscle strength, and bone health. Supplementation in combination products may support patients who require concurrent metabolic correction.

This triple combination is often prescribed when dual therapy alone does not provide adequate glycaemic control or when Vitamin D supplementation is clinically beneficial.

The uses of Gluconorm G2 D Tablet SR are as follows:

Type 2 Diabetes Mellitus

Helps improve fasting and post-meal blood glucose control.

Insulin Resistance

Supports improved glucose utilisation in peripheral tissues.

Combination Oral Antidiabetic Therapy

Used when monotherapy is insufficient.

Metabolic Support in Diabetic Patients

Vitamin D supports broader metabolic health.

Patients Requiring Vitamin D Supplementation Alongside Diabetes Management

Helps address associated nutritional support where clinically indicated.

Here are the benefits of Gluconorm G2 D Tablet SR:

• Provides multi-mechanism glucose control: Combines insulin release, reduced glucose production, and improved insulin sensitivity.

• Improves fasting and postprandial glucose levels: Dual antidiabetic action targets multiple glucose pathways.

• Supports metabolic health: Vitamin D contributes to bone and muscle support.

• Convenient combination therapy: Reduces pill burden in patients requiring multiple agents.

• Helps improve long-term glycaemic control: Supports HbA1c reduction when used regularly.

• Addresses common Vitamin D deficiency in diabetic patients: Useful where supplementation is clinically needed.

Like all medicines, Gluconorm G2 D Tablet SR may cause side effects in some individuals, especially during initiation or dose adjustment.

Common Side Effects

• Hypoglycaemia: Low blood sugar may occur due to Glimepiride, especially if meals are delayed.

• Nausea: Metformin commonly causes mild nausea initially.

• Abdominal Discomfort: Bloating or mild stomach upset may occur.

• Diarrhoea: Common during early Metformin use.

• Headache: Mild headache may occur in some patients.

Uncommon Side Effects

• Loss of Appetite: Temporary reduction in appetite may occur.

• Metallic Taste: A metallic taste is sometimes reported with Metformin.

• Dizziness: May occur during blood sugar fluctuations.

Serious Side Effects (Require Immediate Medical Attention)

• Severe Hypoglycaemia: Sweating, confusion, tremor, or fainting requires urgent correction.

• Lactic Acidosis: Rare but serious Metformin-related complication requiring urgent attention.

• Severe Allergic Reaction: Rash, swelling, or breathing difficulty requires urgent review.

• Always consult your doctor if side effects persist or worsen.

To ensure safe and effective use:

• Take exactly as prescribed.

• Usually taken with meals to reduce gastric irritation.

• Swallow tablet whole with water.

• Take at the same time daily.

• Do not skip meals while taking this medicine.

• Do not alter dose without medical advice.

Gluconorm G2 D Tablet SR works through three complementary mechanisms.

Glimepiride stimulates insulin release from pancreatic beta cells by closing ATP-sensitive potassium channels, leading to increased insulin secretion.

Metformin reduces hepatic glucose production, improves peripheral insulin sensitivity, and decreases intestinal glucose absorption, helping lower blood sugar without directly increasing insulin secretion.

Vitamin D supports calcium metabolism and may contribute to insulin receptor activity and metabolic regulation, particularly in individuals with deficiency.

Together, these mechanisms improve glycaemic control through pancreatic, hepatic, peripheral, and metabolic pathways.

• Monitor blood glucose regularly.

• Do not skip meals.

• Carry glucose source if hypoglycaemia risk exists.

• Follow regular HbA1c monitoring.

• Maintain exercise and dietary discipline.

• Store below 25°C

• Keep away from moisture

• Keep in original packaging

• Keep out of reach of children

Gluconorm G2 D Tablet SR should preferably be taken with food to reduce gastrointestinal discomfort. However:

• Take with meals regularly: Consistent meal timing helps reduce the risk of hypoglycaemia associated with Glimepiride.

• Avoid excessive alcohol intake: Alcohol may increase the risk of hypoglycaemia and rare Metformin-associated lactic acidosis.

• Follow a balanced diabetic diet: Controlled carbohydrate intake improves overall glycaemic response to treatment.

• Maintain adequate hydration: Good hydration supports kidney function, which is important during Metformin therapy.

Glimepiride + Metformin + Vitamin D may interact with:

• Insulin and Other Antidiabetic Medicines: Combined use may increase the risk of hypoglycaemia and requires blood sugar monitoring.

• Corticosteroids: Steroids may raise blood glucose levels and reduce antidiabetic effectiveness.

• Diuretics: Certain diuretics may affect kidney function and alter glucose control.

• ACE Inhibitors: These may enhance glucose-lowering effect in some patients and occasionally increase hypoglycaemia risk.

• Beta-Blockers: Beta-blockers may mask warning signs of hypoglycaemia such as palpitations or tremor.

• NSAIDs (e.g. ibuprofen, diclofenac): Some NSAIDs may influence blood glucose and kidney function when used repeatedly.

• Contrast Media (iodinated contrast agents): Temporary interruption of Metformin may be required before and after certain imaging procedures involving contrast.

Gluconorm G2 D Tablet SR should be used carefully in:

• Renal Impairment: Metformin may accumulate in reduced kidney function and increase the risk of lactic acidosis.

• Hepatic Impairment: Liver dysfunction may alter glucose metabolism and increase treatment-related risks.

• Hypoglycaemia-Prone States: Patients with irregular meals, poor intake, or frailty may be more susceptible to low blood sugar.

• Vitamin B12 Deficiency: Long-term Metformin use may reduce Vitamin B12 absorption in some individuals.

• Heart Failure: Careful monitoring is required, especially if kidney perfusion is compromised.

• Severe Infection or Acute Illness: Temporary changes in diabetic treatment may be needed during acute physiological stress.

• Dehydration: Fluid depletion may increase the risk of kidney-related complications and lactic acidosis.

The dose depends on blood glucose levels, response, and clinical requirement. It should be taken exactly as prescribed by your doctor.

If you miss a dose, take it when remembered unless the next dose is due soon. Do not double the dose.